Cristalia products with Nemera’s reusable pen injector commercialized in Brazil.
![](https://www.nemera.net/wp-content/uploads/2024/01/Crispen-caixa-white-back.png)
![](https://www.nemera.net/wp-content/uploads/2024/01/Crispen-caixa-white-back.png)
05/06/2024
Read our 2023 ESG report to know more where we stand today on sustainability, our strategic priorities and objectives
Continue Reading28/02/2024
The Index, is calculated from 4 to 5 indicators depending on whether the company has less or more than 250 employees and takes into account
Continue Reading30/01/2024
Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.
Continue Reading28/11/2023
Know more about the treatment area of Nose to brain that Nemera can offer
Continue Reading12/09/2022
Located in the bio district of Gerland, the BREEAM certified collaborative space will house Nemera’s headquarters & European innovation teams. Morning coffee on the rooftop taking in a view ...
Continue Reading25/02/2022
L’Index, se calcule à partir de 4 à 5 indicateurs selon que l’entreprise fait moins ou plus de 250 salariés et prend en compte : L’écart de rémunération femmes-hommes, L’é...
Continue Reading